Advanced Biomed Inc. (ADVB)

Advanced Biomed Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Selling, General & Admin	-	-0.75	-0.1
Research & Development	-	-1.62	-1.73
Other Operating Expenses	0	-1.62	0
Operating Expenses	-	-3.99	-1.84
Operating Income	-4.75	-3.99	-1.84
Interest Expense / Income	-0	-0	-0
Other Expense / Income	-0	0.04	0
Pretax Income	-4.75	-4.03	-1.84
Net Income	-4.75	-4.03	-1.84
Free Cash Flow	-5.38	-2.05	-0.5
EBITDA	-4.44	-3.9	-1.78
Depreciation & Amortization	0.31	0.13	0.06
EBIT	-4.75	-4.03	-1.84

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).